Construction and Validation of a Model for Predicting Impaired Fasting Glucose Based on More Than 4000 General Population

References

• American Diabetes Association. 2. classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl1):S14–S31. doi:10.2337/dc20-S002
   PubMedGoogle Scholar
• Gong Q, Zhang P, Wang J, et al. Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: a post hoc analysis of Da Qing diabetes prevention outcome study. Diabetes Obes Metab. 2021;23(10):2385–2394. doi:10.1111/dom.14481
   PubMed Web of Science ®Google Scholar
• Hibi M, Hari S, Yamaguchi T, Mitsui Y, Kondo S, Katashima M. Effect of short-term increase in meal frequency on glucose metabolism in individuals with normal glucose tolerance or impaired fasting glucose: a randomized crossover clinical trial. Nutrients. 2019;11(9):2126. doi:10.3390/nu11092126
   PubMed Web of Science ®Google Scholar
• Sampson M, Clark A, Bachmann M, et al. Lifestyle intervention with or without lay volunteers to prevent type 2 diabetes in people with impaired fasting glucose and/or nondiabetic hyperglycemia: a randomized clinical trial. JAMA Intern Med. 2021;181(2):168–178. doi:10.1001/jamainternmed.2020.5938
   PubMed Web of Science ®Google Scholar
• Jeong S, Min Cho J, Kwon YI, Kim SC, Yeob Shin D, Ho Lee J. Chitosan oligosaccharide (GO2KA1) improves postprandial glycemic response in subjects with impaired glucose tolerance and impaired fasting glucose and in healthy subjects: a crossover, randomized controlled trial. Nutr Diabetes. 2019;9(1):31. doi:10.1038/s41387-019-0099-4
   PubMedGoogle Scholar
• Kim MK, Han K, Koh ES, et al. Cumulative exposure to impaired fasting glucose and future risk of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2021;175:108799. doi:10.1016/j.diabres.2021.108799
   PubMed Web of Science ®Google Scholar
• Wang X, Zhou YF, Huang Z, et al. Changes in impaired fasting glucose and borderline high low-density lipoprotein-cholesterol status alter the risk of cardiovascular disease: a 9-year prospective cohort study. Front Cardiovasc Med. 2022;9:882984. doi:10.3389/fcvm.2022.882984
   PubMed Web of Science ®Google Scholar
• Lind V, Hammar N, Lundman P, et al. Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure. Cardiovasc Diabetol. 2021;20(1):227. doi:10.1186/s12933-021-01422-3
   PubMed Web of Science ®Google Scholar
• Zupo R, Castellana F, Sardone R, et al. Impaired fasting plasma glucose is a risk indicator of interventricular septum thickening among non-diabetic subjects with obesity. Diabetes Res Clin Pract. 2020;169:108436. doi:10.1016/j.diabres.2020.108436
   PubMed Web of Science ®Google Scholar
• Jin C, Li G, Rexrode KM, et al. Prospective study of fasting blood glucose and intracerebral hemorrhagic risk. Stroke. 2018;49(1):27–33. doi:10.1161/STROKEAHA.117.019189
   PubMed Web of Science ®Google Scholar
• Lee SH, Han K, Kwon HS, Kim MK. Frequency of exposure to impaired fasting glucose and risk of mortality and cardiovascular outcomes. Endocrinol Metab. 2021;36(5):1007–1015. doi:10.3803/EnM.2021.1218
   Google Scholar
• Bommer C, Sagalova V, Heesemann E, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41(5):963–970. doi:10.2337/dc17-1962
   PubMed Web of Science ®Google Scholar
• Bragg F, Li L, Yang L, et al. Risks and population burden of cardiovascular diseases associated with diabetes in China: a prospective study of 0.5 million adults. PLoS Med. 2016;13(7):e1002026. doi:10.1371/journal.pmed.1002026
   PubMed Web of Science ®Google Scholar
• Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2(8):634–647. doi:10.1016/S2213-8587(14)70102-0
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Prevalence of diabetes and impaired fasting glucose in adults – United States, 1999–2000. MMWR Morb Mortal Wkly Rep. 2003;52(35):833–837.
   PubMedGoogle Scholar
• Rutkowski M, Wojciechowska A, Śmigielski W, et al. Prevalence of diabetes and impaired fasting glucose in Poland in 2005–2014: results of the WOBASZ surveys. Diabet Med. 2020;37(9):1528–1535. doi:10.1111/dme.14333
   PubMed Web of Science ®Google Scholar
• Tian H, Song G, Xie H, Zhang H, Tuomilehto J, Hu G. Prevalence of diabetes and impaired fasting glucose among 769,792 rural Chinese adults. Diabetes Res Clin Pract. 2009;84(3):273–278. doi:10.1016/j.diabres.2009.03.015
   PubMed Web of Science ®Google Scholar
• Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:m997. doi:10.1136/bmj.m997
   PubMed Web of Science ®Google Scholar
• Zhang J, Kong W, Xia P, et al. Impaired fasting glucose and diabetes are related to higher risks of complications and mortality among patients with coronavirus disease 2019. Front Endocrinol. 2020;11:525. doi:10.3389/fendo.2020.00525
   PubMed Web of Science ®Google Scholar
• Byeon H. Exploring the risk factors of impaired fasting glucose in middle-aged population living in South Korean communities by using categorical boosting machine. Front Endocrinol. 2022;13:1013162. doi:10.3389/fendo.2022.1013162
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang L, Su Y, Zhong L, Peng B. Prediction model for the onset risk of impaired fasting glucose: a 10-year longitudinal retrospective cohort health check-up study. BMC Endocr Disord. 2021;21(1):211. doi:10.1186/s12902-021-00878-4
   PubMed Web of Science ®Google Scholar
• Lin SX, Berlin I, Younge R, et al. Does elevated plasma triglyceride level independently predict impaired fasting glucose?: the multi-ethnic study of atherosclerosis (mesa). Diabetes Care. 2013;36(2):342–347. doi:10.2337/dc12-0355
   PubMed Web of Science ®Google Scholar
• Rutkowski M, Bandosz P, Czupryniak L, et al. Prevalence of diabetes and impaired fasting glucose in Poland--The NATPOL 2011 study. Diabet Med. 2014;31(12):1568–1571. doi:10.1111/dme.12542
   PubMed Web of Science ®Google Scholar
• Zhao Q, Zhen Q, Li Y, et al. Prevalence and risk factors of impaired fasting glucose among adults in northeast China: a cross-sectional study. Endocr Pract. 2018;24(7):677–683. doi:10.4158/EP-2018-0046
   PubMed Web of Science ®Google Scholar
• Li S, Guo S, He F, et al. Prevalence of diabetes mellitus and impaired fasting glucose, associated with risk factors in rural Kazakh adults in Xinjiang, China. Int J Environ Res Public Health. 2015;12(1):554–565. doi:10.3390/ijerph120100554
   PubMed Web of Science ®Google Scholar
• Zhang FL, Xing YQ, Guo ZN, Wu YH, Liu HY, Yang Y. Prevalence and risk factors for diabetes and impaired fasting glucose in Northeast China: results from the 2016 China National Stroke Screening Survey. Diabetes Res Clin Pract. 2018;144:302–313. doi:10.1016/j.diabres.2018.09.005
   PubMed Web of Science ®Google Scholar
• Bhat S, Jagadeeshaprasad MG, Patil YR, et al. Proteomic insight reveals elevated levels of albumin in circulating immune complexes in diabetic plasma. Mol Cell Proteomics. 2016;15(6):2011–2020. doi:10.1074/mcp.M116.058008
   PubMed Web of Science ®Google Scholar
• Gao Y, Xu B, Yang Y, et al. Association between serum uric acid and carotid intima-media thickness in different fasting blood glucose patterns: a case-control study. Front Endocrinol. 2022;13:899241. doi:10.3389/fendo.2022.899241
   PubMed Web of Science ®Google Scholar
• Braga T, Kraemer-Aguiar LG, Docherty NG, Le Roux CW. Treating prediabetes: why and how should we do it? Minerva Med. 2019;110(1):52–61. doi:10.23736/S0026-4806.18.05897-4
   PubMed Web of Science ®Google Scholar